Cargando…
HBV Core Promoter Inhibition by Tubulin Polymerization Inhibitor (SRI-32007)
Approximately 257 million people chronically infected with hepatitis B virus (HBV) worldwide are at risk of developing hepatocellular carcinoma (HCC). However, despite the availability of potent nucleoside/tide inhibitors, currently there are no curative therapies for chronic HBV infections. To iden...
Autores principales: | Kalkeri, Raj, Peng, Junzhong, Huang, Chunsheng, Cai, Zhaohui, Ptak, Roger G., Suto, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582060/ https://www.ncbi.nlm.nih.gov/pubmed/33110426 http://dx.doi.org/10.1155/2020/8844061 |
Ejemplares similares
-
The structured core of human β tubulin confers isotype-specific polymerization properties
por: Pamula, Melissa C., et al.
Publicado: (2016) -
Physiological regulation of total tubulin and polymerized tubulin in tissues
Publicado: (1977) -
Novel indole-bearing combretastatin analogues as tubulin polymerization inhibitors
por: Kumar, Sunil, et al.
Publicado: (2013) -
Sulfhydryls and the in vitro polymerization of tubulin
Publicado: (1976) -
Efficacy of the novel tubulin polymerization inhibitor PTC‐028 for myelodysplastic syndrome
por: Zhong, Cheng, et al.
Publicado: (2020)